M
600993
vs
NOVO B

Over the past 12 months, Mayinglong Pharmaceutical Group Co Ltd has significantly outperformed NOVO B, delivering a return of +8% compared to the NOVO B's 55% drop.
Smart Verdict
AI-Powered
Let AI Decide.


Valuation Comparison

Growth Comparison
Growth Over Time
600993 vs NOVO B
All metrics are calculated based on data from the last 10 years.
Profitability Comparison
Gross Margin
Operating Margin
Net Margin
FCF Margin
ROE
ROA
ROIC
ROCE
Solvency Comparison
Stocks Performance
Stocks Performance
600993 vs NOVO B
Performance Gap
600993 vs NOVO B
Performance By Year
600993 vs NOVO B

